Pharma and Biotech
No deals were found in the last 365 days.
No deals were found in the last 365 days.
No director shareholdings found for this company
| Notifier** | Holding | Value* |
|---|---|---|
| Mark H Dixon and Diana Dixon | 76,000,000 | £7,505,000 |
| Mark H Dixon | 50,000,000 | £4,937,500 |
| David Campbell Brierwood | 16,416,813 | £1,621,160 |
| Tyndall Investment Management | 13,165,553 | £1,300,098 |
| Tyndall Investment Management | 13,165,553 | £1,300,098 |
| Seneca Partners Limited | 10,561,405 | £1,042,939 |
| Unicorn Asset Management Limited | 7,894,736 | £779,605 |
| Andrew McBain | 4,301,433 | £424,766 |
| Currency | UK Pounds |
| Share Price | 9.88p |
| Change Today | -0.38p |
| % Change | -3.66 % |
| 52 Week High | 10.25 |
| 52 Week Low | 9.50 |
| Volume | 405,981 |
| Shares Issued | 259.04m |
| Market Cap | £25.58m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:29 | 6,921 @ 10.06p |
| 16:24 | 7,500 @ 9.68p |
| 16:05 | 2,250 @ 9.67p |
| 16:04 | 4,000 @ 9.67p |
| 15:55 | 44,444 @ 9.90p |
You are here: research